•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Healthcare Realty Trust Announces Second Quarter Earnings Release Date and Conference Call
enGene Reports Second Quarter 2026 Financial Results and Provides Business Update
New Strong Buy Stocks for June 8th
Camizestrant Combination Delayed Time to First Progression by 55% and to Second Progression by 37% in Patients With Advanced HR-positive Breast Cancer With an Emergent ESR1 Tumor Mutation in SERENA-6
Ivonescimab with Chemotherapy Demonstrated a Statistically Significant Overall Survival Benefit Compared to Tislelizumab Plus Chemotherapy in 1L Treatment of Patients with Squamous NSCLC in the HARMON
Exelixis Announces Results from Subgroup Analysis of Phase 3 CABINET Pivotal Trial Evaluating CABOMETYX® (cabozantinib) in Non-Functional and Functional Neuroendocrine Tumors at ASCO 2026
Healthcare Realty Trust: Betting On Outpatient Demand Growth, Lower Operator Risk (Upgrade)
ENHERTU® (fam-trastuzumab deruxtecan-nxki) approved in the US for two new indications for patients with HER2-positive early breast cancer
H&R Real Estate Investment Trust (HR.UN:CA) Q1 2026 Earnings Call Transcript
D2L Survey Reveals How AI is Beginning to Reshape Entry-Level Work and the Talent Pipeline
Healthcare Realty Announces Pricing of Upsized $600 Million Exchangeable Senior Notes Offering
Healthcare Realty Announces Proposed Exchangeable Senior Notes Offering
REITs Excel, Earnings Swell, Fed Rebels
Healthcare Realty Trust Incorporated (HR) Q1 2026 Earnings Call Transcript
Healthcare Realty Reports First Quarter 2026 Results and Increases Full Year 2026 Guidance
A Fragile Truce
Healthcare Realty Trust Announces First Quarter Earnings Release Date and Conference Call
Healthcare Realty: Mispriced High-Yield Bargain
Healthcare Realty Trust (NYSE:HR) versus Sila Realty Trust (NYSE:SILA) Head-To-Head Contrast
What Active REIT Managers Bought And Sold In Q4 2025